View Single Post
phion
#1
Feb4-13, 04:23 PM
PF Gold
phion's Avatar
P: 55
A Techwise Conversation with Nina Tandon, EE and tissue engineer
BY STEVEN CHERRY // WED, JANUARY 30, 2013

Testing newly developed drugs is utterly necessary, but it’s not without its problems. For one thing, it’s expensive. For another, it’s not very accurate—it usually starts with mice, and they’re not like people in the ways we need them to be. It continues with humans, and often even human subjects are not like the people needing the drug, in the ways we need them to be. And we’re putting those people at risk. And did I mention how expensive it is?
link

iPSCs

Nina Tandon
Phys.Org News Partner Medical research news on Phys.org
Counselling has limited benefit on young people drinking alcohol
Experts question value of common superbug control practices
Blueprint for next generation of chronic myeloid leukemia treatment